Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications by Kirimlioglu, H et al.
') I ~ 3 
0" 
Hepatocellular Carcinomas in Native Livers From Patients 
Treated With Orthotopic Liver Transplantation: 
Biologic and Therapeutic Implications 
HALE KIRIMLIOGLU,1 IGOR DVORCHICK,2,3 KRls RUPPERT,3 SYDNEY FINKELSTEIN, 1 ]. WALLIS MARSH,2 SHUNZABURO IWATSUKI,2 
ANDREW BONHAM,2 BRIAN CARR,2 MICHAEL NALESNIK,1 GEORGE MICHALOPOULOS,1 THOMAS STARZL,2 
JOHN FUNG,2 AND ANTHONY DEMETRISI 
The gross and histopathologic characteristics of 212 non-
fibrolamellar hepatocellular carcinomas (HCCs) discovered 
in native livers removed at the time of liver transplantation 
were correlated with features of invasive growth and tumor-
free survival. The results show that most HCCs begin as 
small well-differentiated tumors that have an increased pro-
liferation rate and induce neovascularization, compared 
with the surrounding liver. But at this stage, they maintain a 
near-normal apoptosislmitosis ratio and uncommonly show 
vascular invasion. As tumors enlarge, foci of dedifferentia-
tion appear within the neoplastic nodules, which have a 
higher proliferation rate and show more pleomorphism than 
surrounding better-differentiated areas. Vascular invasion, 
which is the strongest predictor of disease recurrence, cor-
relates significantly with tumor number and size, tumor gi-
ant cells and necrosis, the predominant and worst degree of 
differentiation, and the apoptosislmitosis ratio. In the ab-
sence of macroscopic or large vessel invasion, largest tumor 
size (P < .006), apoptosislmitosis ratio (P < .03), and num-
ber of tumors (P < .04) were independent predictors of 
tumor-free survival and none of 24 patients with tumors 
having an apoptosislmitosis ratio greater than 7.2 had recur-
rence. A minority of HCCs « 15%) qUickly develop aggres-
sive features (moderate or poor differentiation, low apopto-
sis/mitosis ratio, and vascular invasion) while still small, 
similar to flat carcinomas of the bladder and colon. In con-
clusion, hepatic carcinogenesis in humans is a multistep and 
multifocal process. As in experimental animal studies, ag-
gressive biologic behavior (vascular invasion and recur-
rence) correlates significantly with profound alterations in 
the apoptosislmitosis ratio and with architectural and cyto-
logic alterations that suggest a progressive accumulation of 
multiple genetic abnormalities. (HEPATOLOGY 2001;34: 
502-510.) 
Abbreviations: HCC, hepatocellular carcinoma; HPF, high power field. 
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Hepatic carcinogenesis is a multicentric process divided 
classically into the 3 stages of initiation, promotion, and pro-
gression.l-7 Initiation, an irreversible step marked by DNA 
damage and mutations, confers upon initiated cells, a poten-
tial growth advantage over surrounding cells. In the proper 
promoting environment, initiated cells undergo clonal expan-
sion because of less responsiveness to negative growth con-
straints, altered responses to Signals for growth or terminal 
differentiation, andlor resistance to the cytotoxicity and mi-
toinhibitory effects of carcinogens. The altered foci may be 
capable of autonomous or clonal growth,4,8-IO but mainte-
nance of a near-normal mitosis/apoptosis rati06 limits expan-
sion such that the foci may not be grossly or microscopically 
distinct from the surrounding liver. "',8-10 Tumor progression 
refers to accumulation of additional genetic defects that pro-
foundly alter tumor growth, especially the relationship be-
tween mitosis and apoptosis6 and the capacity for invasive and 
metastatic growth. 
Tumor progression can be divided clinically into curable 
and noncurable stages, which obviously are disease and treat-
ment specific. We previously developed a statistical model 
allowing prognostication of hepatocellular carcinoma (HCC) 
recurrence after liver transplantation, based on routine gross 
and microscopic pathologic tumor characteristics (grade of 
vascular invasion, number of tumors, largest tumor size, lobar 
distribution).ll-l ... The model allowed unambiguous identifi-
cation of certain combinations of tumor characteristics that 
always or never led to recurrence. Unfortunately, in 30% of 
cases the same combination was associated with an opposite 
clinical outcome.lI-l'I 
The goal of this study was to determine whether concepts 
derived from experimental animal hepatic carcinogenesis 
could be applied to the study of human HCC, and thereby 
enhance the predictive power of modeling. Therefore, we 
characterized all HCCs present in native livers removed at the 
time of transplantation, which prOvided an opportunity to 
study the entire spectrum of tumorogenesis, because most of 
the transplantations were performed for underlying cirrhosis 
or a combination of cirrhosis and tumor. An emphasis on 
features important in tumor progression enabled us to corre-
late gross and histopathologic tumor characteristics with vas-
cular invasion and tumor-free survival after transplantation. 
MATERIALS AND METHODS 
Patient Population. The study (IRB protocols #000625 and 
9507150) analyzed 212 of 358 native hepatectomy specimens con-
taining HCC from a total of 3,432 orthotopic liver transplantation 
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procedures performed between January 1981 and December 1999 at 
the Thomas E. Starzl Transplant Institute, University of Pittsburgh 
Medical Center. Fibrolamellar variants ofHCC in noncirrhotic livers 
were excluded; and the blocks and slides from the remaining cases 
with HCC were unavailable for review. WIlen more than one tumor 
nodule was identified, it was not always possible to distingUish inde-
pendent primary tumors from intrahepatic metastasis (-es) from a 
single primary, on the basis of morphologic criteria alone. Any co-
existent disease diagnosis was established using standard clinical and 
histopathologic criteria with clinicopathologic correlation. Demo-
graphic data including patient age, gender, and follow-up and other 
tumor information was obtained from the Electronic Data Interface 
for Transplantation (EDIT), which is a database maintained by the 
Thomas E. Starzl Transplant Institute. Tumor size and number and 
lobar distribution were obtained from the surgical pathology reports. 
Routine Histopathologic Studies. Gross examination and histologic 
sectioning of the hepatectomy specimens were examined according 
to a previously published protoco!.15 Routine hematoxylin and eosin 
stained sections of the tumor(s) were analyzed for predominant and 
worst grade of differentiation, growth pattern(s), microscopic or an-
giolymphatic and macroscopic or larger vessel invasion, necrosis, 
giant cells, and clear cell change (Fig. lA-G). Evidence of distant 
metastases, lymph node metastases, resection margins, and infiltra-
tion of other organs was obtained from the clinical records and sur-
gical pathology reports. Tumor differentiation was graded as well, 
moderate, and poor (Fig. lA-G). The areas of worst differentiation 
were selected for counting metaphase mitotic figures and apoptotic 
cells (Fig. IH-I), but areas near tumor necrosis were avoided. The 
apoptotic and mitotic index were determined by counting the total 
number of mitotic or apoptotic cells in 10 randomly selected high 
power fields (HPF) (X400). Vascular invasion was divided into mi-
croscopic or angiolymphatic infiltration (small thin-walled vessels) 
and macroscopic or larger-vessel (typical veins or arteries) invasion 
(Fig. lK-L). Tumor necrosis, tumor giant cells, and clear cell change 
were recorded as present or absent, but not graded (Fig. IF-J). 
The surrounding liver was examined for the presence and type of 
cirrhosiS, the activity level of chronic hepatitis, if present, and portal 
vein thrombosis. Chronic active hepatitis was graded as follows: 0, 
inactive; I, minimally active; and 2, active; based on a combination of 
the severity of inflammation and interface activity. 
Immunohistochemical Analyses. From the 212 cases analyzed above, 
55 were randomly selected for a more detailed immunohistochemi-
cal analysis using identifiers of cell proliferation (Ki-67; Mib-l clone; 
Immunotech, Westbrook, ME) and tumor angiogenesis (anti-human 
a smooth muscle actin; lA4; LotllO; 1:30 dilution; DAKO, Carpin-
teria, CA). Staining was performed on the section containing the area 
of worst differentiation and on nontumorous liver using a standard 
indirect avidin-biotin complex technique. All Ki-67+ hepatocytes 
were counted, regardless of the intensity of the staining in 10 HPF 
(X400). The distribution of Ki-67 staining within the tumors and 
non tumorous livers was classified as homogenous and nonhomog-
enous. 
The pattern of smooth muscle actin staining was divided into 
single complete vessels and branching, sinusoid-like channels (Fig. 
2A-C). For scoring purposes, the number of complete vessels was 
counted in 10 HPF. The sinusoid-like vasculature was scored as 
follows: 0, no sinusoid-like pattern; +, weakly stained discontinuous 
and focal vessels; + + , weakly stained diffuse branching vessels/focal 
well-formed vessels; and + + +, diffuse well-formed sinusoid-like 
vessels. The distribution of each type of vessels was classified as 
either homogenous or nonhomogenous. 
Statistical Analyses. CategOrical variables were compared by using 
the X2 likelihood ratio test or Fisher's exact test when appropriate. 
Ordinal or interval variables were compared with the Kruskal-Wallis 
test or Wilcoxon-Mann-Whitney U test when only 2 groups were 
compared. The Kaplan-Meier method was used for analysis of impact 
of the studied pathologic characteristics of HCC on tumor-free sur-
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viva!. Significance level was set up at .05. The stepwise Cox regres-
sion model with likelihood ratio test for variable selection was used 
to determine independent pathologic predictors ofHCC recurrence. 
RESULTS 
Characteristics of the Patients With HCC in the Native Liver. The 
study patients were predominantly men (159 men, 53 women), 
and ranged in age from 18 to 76 years (mean :I:: SD = 53.9 :I:: 
9.6 years). Most ofthe patients had at least one risk factor for 
HCC, as evidenced by the etiology for the underlying cirrho-
sis, which was present in 197 of 212 (92.8%) cases (Table 1). 
The causes of the underlying liver disease were hepatitis C 
virus-induced (n = 60) or hepatitis B virus-induced (n = 38) 
cirrhosis (4 had both), ethanol abuse (n = 42), cryptogenic 
cirrhosis (n = 22), non-A, non-B chronic hepatitiS (n = 20; 
pre-1990), autoimmune hepatitis (n = 7), primary biliary 
cirrhosis (n = 5), and primary sclerosing cholangitis (n = 2). 
The 25 remaining cases fell into other miscellaneous catego-
ries, such as metabolic diseases and chronic hepatitis, not 
otherwise speCified. 
Gross and Microscopic Characteristics of the Liver and HCC. The 
pattern of cirrhosis was mixed in 113 (57.4%); the remaining 
livers showed a predominantly macro nodular (n = 46; 
23.3%) or micronodular cirrhosis (n = 38; 19.3%). The hep-
atitis activity level, when present, was judged as mild in 79 
(37.3%) and severe in 105 (49.5%). One fourth of the cases 
(n = 50; 23.6%) had gross evidence of portal vein thrombosis. 
A single tumor was present in 105 cases, 29 cases had 2 
nodules, 7 cases had 3 nodules, and more than 3 tumor nod-
ules were detected in 71 cases. When limited to a Single lobe 
(n = 149), most tumors developed in the right lobe (125 right, 
19 left, 4 caudate, 1 quadrate lobe). Multilobar involvement 
was seen in 63 cases. The median size of single and multiple 
tumors was 1.8 and 3.0 em, respectively, with a standard de-
viation of 3.5 em for both groups. Tumor was present in the 
resection margin in 13 (6.1%) cases, and 5 had lymph node 
metastasis. 
Most HCCs appear to begin as small well-differentiated 
neoplasms, but eventually show heterogeneous histologic 
growth and differentiation patterns, consistent with the con-
cept of tumor evolution (Fig. 3A-F). For example, most small 
single tumors (:51.0 em) were predominantly (23 of28; 82%) 
or exclusively (13 of 28; 46%) well differentiated and did not 
show any evidence of vascular invasion (26 of28; 93%). A few 
of these small Single tumors however, showed predominantly 
or exclUSively moderate or poor differentiation (4 of 28; 14%). 
Of all predominantly well-differentiated tumors, only 39 of 
102 (38%) were exclusively well differentiated (i.e., the pre-
dominant grade same as the worst grade), and all but 3 of 
these tumors were 3 em or less. In larger E~RKM em) Single 
tumors, only 3 of 16 (19%) were predominantly well differ-
entiated and none were exclusively well differentiated. Eight 
of 10 (80%) exclUSively poorly differentiated tumors were 3 
em or greater. 
A trabecular pattern predominated in 174 cases and was the 
secondary pattern in 21 cases; a pseudo-acinar pattern was 
observed in 66 cases and predominated in 29 cases. Clear cell 
change was present in 93 (43.9%) and giant tumor cells in 82 
(38.7%) cases. Slightly more than one third (n = 78; 36.8%) of 
the tumors showed necrosis. One half of the tumors (n = 102; 
48.1 %) showed microscopic or angiolymphatic invasion and a 
subset of these (n = 40; 18.9%) also showed macroscopic or 
larger vessel involvement. The mitotic figure count in the 
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FIG. 1. Illustration of the various routine histopathologic parameters evaluated in the HCC present in the native livers removed at the time of transplan-
tation. (A) Well-differentiated HCC; (B) pseudo-acinar growth pattern; (C) fibrolamellar-like growth pattern; (D) moderately differentiated HCC; (E) poorly 
differentiated HCC; (F) clear cell change; (G) multi- and mononuclear tumOr giant cells; (H) mitoses; (I) apoptosis (inset shOwing greater detail); Ul tumoral 
necrosis (bottom right); (K) microscopic or angiolymphatic invasion; (l) macroscopiC or arterial invasion. 
areas of worst differentiation ranged from 1 to 42 per 10 HPF 
(X400) (mean = 10.9::'::: 8.9, median = 9) . In the same areas, 
apoptosis counts ranged from 4 to 69 per 10 HPF (mean = 
32.2::'::: 15.2, median = 31). The ratio of apoptosis to mitosis 
in the same area ranged from 1.09 to 31 (mean = 4.74 ::'::: 4.12, 
median = 3.63). 
Correlation Between Different Tumor Characteristics. Recogni-
tion of vascular invasion is a direct indication of tumor aggres-
HEPATOLOGY Vol. 34. No, 3. 2001 
FIG, 2. Grading of tumor angiogenesis, (A) Diffuse 
prominent sinusoidal-like vessels (++ +); (6) weakly 
stained. diffuse sinusoidal-like vessels (+ +); (e) weakly 
stained. discontinuous sinusoidal-like vessels; and (D) 
countable complete vessel pattern. Recognition of tumor an-
giogenesis. (E) Note the development of the sinusoidal-like 
tumor angiogenesis within the tumor (right). in contrast to 
the surrounding non-neoplastic liver (left) , (F) Tumor an-
giogenesisalso varied in different areas of an evolving tumor. 
Note the combination of the sinusoidal-like vessels and sin-
gle complete vessels in the moderate ly differentiated area of 
the Hee (left) , which evolved from a well-differentiated tu-
mor that shows only a weak sinusoidal pattern (right), 
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TABLE 1. Etiology of Underlying Cirrhosis, Which Was Present in 197 of 
212 Cases With Coexistent HCC in the Native Liver Removed 
at Transplantation 
Etiology of Cirrhosis 
Hepatitis C virus 
Hepatitis B virus 
Ethanol abuse 
Cryptogenic cirrhosis 
Non-A, non-B chronic hepatitis (pre-1990) 
Autoimmune hepatitis 
Primary biliary cirrhosis 
Primary scleroSing cholangitis 
Other 
Number of Cases' 
60 
38 
42 
22 
20 
7 
6 
2 
2S 
'Some of the patients have more than one disease and are listed under each. 
siveness and is the single most significant predictor of tumor 
recurrence after transplantation. 13·16 Microscopic or angi-
olymphatic invasion correlates significantly with tumor nod-
ule number and tumor size as well as the presence of giant 
cells and necrosis (P < .01; Table 2). There was also a signif-
icant correlation between angiolymphatic invasion and the 
predominant and worst degree of differentiation (P < .01; 
Table 3). The predominant differentiation pattern is more 
predictable of angiolymphatic invasion for the poorly differ-
entiated cases, but the worst degree of differentiation better 
predicted angiolymphatic invasion in the well-differentiated 
cases. If the predominant differentiation was poor, all of the 
cases 00 of 10; 100%) had some level of vascular invasion. 
Conversely, if the worst area of the tumor was still well differ-
entiated, then 35 of39 (89.7%) cases did not have any level of 
vascular invasion (Table 3). There were no significant associ-
ations among the presence of clear cell change, histologic 
growth pattern, hepatitis activity, etiology of the primary liver 
disease, and any level of vascular invasion (Table 2). 
There were also Significant correlations between the apo-
ptosisimitosis ratio and other pathologic and clinical (see be-
low) tumor characteristics. For example, both predominant 
and worst degree of differentiation were strongly correlated 
with apoptosis, mitosis, and the apoptosisimitosis ratio (P < 
.01): the ratio decreases with dedifferentiation. There was a 
very strong correlation (P < .0001) between the apoptosisi 
mitosis ratio and the extent of vascular invasion (distribution 
of those with none, microscopic or angiolymphatic, and mac-
roscopic or larger vessel invasion): a lower ratio in those with 
increasing extent of vascular invasion. The apoptosisimitosis 
ratio was also significantly lower in tumors with clear cell 
change (P < .05), giant cells (P < .01) and tumor necrosis 
(P = .001). We failed to establish a Significant correlation 
between tumor number and those parameters. The mean with 
95% CI boundaries for the apoptosisimitosis ratio for the pre-
dominant grade of differentiation is shown in Fig. 4. 
Immunohistochemical Findings. In all the cases studied, the 
number of Ki-6?+ hepatocytes per 10 HPF was Significantly 
higher in the tumor than in the surrounding liver (P < .0001). 
However, in most of the cases (49 of 55; 89%), the apparent 
non-neoplastic hepatocytes in the surrounding liver also 
showed increased Ki-67 labeling (mean 4.81 :!: 4.77; range, a 
to 14; median, 2.5) compared with historical controls of nor-
mal human liverY In general, cases with relatively high Ki-67 
labeling in the non-neoplastic hepatocytes also showed high 
Ki-67 labeling in the tumor and/or had active hepatitis. There 
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were also Significant correlations between apoptosis, mitosis, 
and Ki-67 labeling, as expected, and seen in previous studies 
(P < .01). When the apoptosis/mitosis ratio and Ki-67 label-
ing were compared, again a strong correlation was found, but 
it was slightly lower (P < .05) than for the correlation between 
mitosis and apoptosis (see above). 
Almost all of the tumors (50 of 56; 89.3%) showed a diffuse 
sinusoid-like staining pattern with smooth muscle actin, 
whereas this pattern was not seen in the surrounding non-
neoplastic liver (Fig. 2). Within the tumors, the number of 
vessels (range 3-39; mean 10.2 ::!:: 6.8, median 8) wassignifi-
cantly higher (P < .0 1) than in the surrounding non-neoplas-
tic nodules, which showed no vessels in 37 cases, 1 vessel in 6 
cases, and 2 vessels in 13 cases. Although angiogenesis signif-
icantly correlated with neoplastiC transformation, there was 
no statistical correlation between angiogenesis and mitosis, 
Ki-67, differentiation, vascular invasion, tumor size, or tumor 
number. If the number of complete vessels within a tumor was 
more than 5, the apoptotic cell number decreased and the 
correlation between the vessel number and apoptosis was sta-
tistically Significant (P < .01). 
Tumor vascularity (19 of 56; 34%) and Ki-67 labeling (25 of 
56; 45%) were judged to be heterogeneous within the tumors, 
and the heterogeneity was often rela ted to obvious differences 
in tumor morphology (i.e., differentiation or histologic pat-
tern). However, in other cases regional differences in Ki-67 
labeling within the tumors had no obvious morphologic cor-
relate, except that in 5 cases, staining was increased at the 
periphery of the tumor. There was no significant correlation 
between the tumor growth pattern or clear cell change and 
Ki-67 and/or vessel number or heterogeneity. 
Correlation Between Tumor Characteristics and Tumor-Free Sur-
vival After Transplantation. Because patients with macroscopic 
or larger vessel invasion invariably suffer HCC recurrence, 16 
pathologic examination of native liver becomes especially 
valuable in terms of disease prognosis for patients with no or 
microscopic (angiolymphatic) invasion. To investigate the 
potential role of tumor characteristics for postoperative HCC 
progression in patients without large vessel invasion, the Cox 
proportional hazard model was used. Largest tumor size (P < 
.006), apoptosisimitosis ratio (P < .03), and number of tu-
mors (P < .04) were found to be independent predictors of 
postoperative tumor-free survivaL The hazard of recurrence 
increases 3.1-fold (95% C1: 1.1-8.8) for the apoptosisimitosis 
ratio below 3.5 compared with the respective value above 3.5. 
The apoptosisimitosis ratio alone can also serve as a predic-
tor of disease progression. The patients with tumors showing 
a ratio above 3.5 had significantly superior (P < .002) post-
transplantation tumor-free survival compared with patients 
who had tumors with a lesser ratio (Fig. 5). This finding is not 
surprising because the extent of vascular invasion, which is 
the most important predictor of disease progression, corre-
lates well with the apoptosisimitosis ratio (P < .000l). More-
over, in the absence of macroscopic or large vessel invasion, 
none of 24 patients with the apoptosisimitosis ratio of above 
7.2 had HCC recurrence during the follow-up period (3.4 ::t 
0.5 years). 
The apoptosisimitosis may help distingUish between mul-
tiple versus Single origin of multiple tumors (stage T4 vs. T2 
or 2 T1 tumors). However, tumor genetic analysis is reqUired 
to evaluate this hypotheSiS. 
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FIG. 3. Most of Ihe HCCs showed heterogeneous hiStologic growth and differentiation patterns, consistent with the concept of tumor progression. More 
poorly differentiated areas showing a higher rate of proliferation always developed within a better-differentiated area at the periphery. The same tumor is 
illustrated in (A) smooth muscle actin staining and (B) Ki-67 nuclear labeling. Note that the well-differentiated area is on the left, shows clear cell change, less 
neoangiogenesis, and a lower Ki-67 labeling index, compared with the moderately differentiated area on the right. In an effort 10 capture tumor heterogeneity 
for data analysis, both the predominant and worst grade of differentiation were recorded, The same concept is illustrated in C and 0 (same regions of tumor) 
and E and F (same regions of tumor). Note that the areas of increased cellularity and decreased differentiation show higher Ki-67-labeling indexes than the 
surrounding beuer-differentiated neoplastiC cells. 
DISCUSSION 
This study shows that the multistep and multifocal concept 
of hepatic carcinogeneSiS elucidated largely in experimental 
animal models, can be used to recognize the various stages of 
HCC development in humans and gUide clinical manage-
men , [ ,6,7 It also shows that hepatic tumor biology is similar to 
the sequential evolution of colon 18 and bladder cancer. 19-22 
The majority of HCCs in this study appear to begin as small 
well-differentiated neoplasms without vascular invasion, which is 
similar to other studies,S The distinction between dysplasia 
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TABLE 2. Correlation Between Any Level of Vascular Invasion and 
Various Gross and Histopathologic Tumor Parameters 
Positive for Any 
Negative for '. level of Vascular 
Vascular Invasion Invasion p 
Pattern 
Trabecular 92 (83.6%) 86 (84.3%) .329 
Acinar 12 (10.9%) 13 (12.7%) 
Fibrolamellar 6 (5.5%) 3(3%) 
Giant cell 
(-) 81 (73.6%) 49 (48%) <.01 
(+) 29 (26.4%) 53 (52%) 
Clear cell change 
(-) 68 (61.8%) 51 (50%) .124 
(+) 42 (38.2%) 51 (50%) 
Tumor necrosis 
(-) 90 (81.8%) 44 (43.1%) <.01 
(+) 20 (18.2%) 58 (56.9%) 
Hepatitis activity 
(-) 12 (10.9%) IS (14.7%) .492 
+ 43 (39.1%) 36 (35.3%) 
++ 55 (50%) 51 (50%) 
Tumor number 
1 78 (70.9%) 27 (26.5%) <.01 
2 19 (17.3%) 10 (9.8%) 
3 7 (6.8%) 
Multiple 13 (11.8%) 58 (56.9%) 
Total Cn = 212) 110 102 
and carcinoma in such cases is currently based on the subjec-
tive opinion of the pathologist who relies on a combination of 
architectural and cytological alterations.3,5,23.2'1 The validity of 
this distinction is substantiated by significantly increased 
Ki-67 labeling within the tumor cells25,26 compared with the 
surrounding liver and the induction of tumor angiogenesis 
(diffuse sinusoid-like and/or complete vessels) recognized on 
smooth muscle actin staining. Factor VIII or CD34 staining 
can also be used to highlight endothelial cells of tumor angio-
genesis.27-29 As in bladder carcinogenesis,20 these small well-
differentiated neoplasms show increased cellular prolifera-
tion, but "social" interactions, differentiation, and the ratio of 
cell proliferation to apoptosis remains near normal such that 
complete removal brings about a cure. 
An overriding conclusion of this and other studies in ex-
perimental animals and humans is that HCCs progress.5,6,30-32 
As the tumors enlarge, foci within the HCC become less well 
differentiated: only 18% of all tumors remained exclUSively 
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FIG. 4. Correlation between predominant grade of tumor differentiation 
and apoptosislmitosis ratio. 
well differentiated, and all but 3 of these were smaller than 
3.0 cm. As in other studies,S,23,2'1,32,33 the development of "tu-
mor(s) within a tumor" was recognized histologically by both 
a lesser degree of differentiation or growth pattern, pleomor-
phism, and higher Ki-67 labeling index. In such cases, less 
differentiated foci are always surrounded by better differ-
entiated neoplastic hepatocytes, similar to previous stud-
ies.5,23.2'1,33 
Eventually dedifferentiated foci acquire an ability to invade 
the vasculature and metastasize, as evidenced by the correla-
tion between vascular invasion and recurrence after trans-
plantation.5,16,3'1 Acquisition of these aggressive characteris-
tics is likely attributable to further genetic instability and 
abnormalities, as evidenced by the appearance of tumor giant 
cells and poor differentiation, which lead to profound alter-
ations in growth (apoptosislmitosis ratio), as in experimental 
animal studies6,7,35 and in human breast cancer.36 In fact, the 
increased proliferation observed in the small, well-differenti-
ated lesion may promote genetic instability and tumor pro-
gression.7 Thus, routine histopathologic findings such as vas-
cular invasion, tumor giant cells, and the apoptosislmitosis 
ratio are likely to be surrogate markers of genetic instability 
and abnormalities, marking clinically important events in tu-
mor progression. 
TABLE 3. Correlation Between the Level of Vascular Invasion and the Predominant and Worst Areas of Tumor Differentiation 
Positive for Positive for 
Microscopic or Microscopic and 
Negative for Angiolymphatic Macroscopic Vascular 
Vascular Invasion Invasion Invasion Total 
Predominant differentiation 
Well 72 (70.6%) 18 (17.6%) 12 (11.8%) 102 (48.1%) 
Moderate 37 (37%) 42 (42%) 21 (21%) 100 (47.2%) 
Poor 0(0%) 3 (30%) 7 (70%) 10 (4.7%) 
Worst differentiation 
Well 35 (89.7%) 3 (7.7%) 1 (2.6%) 39 (18.4%) 
Moderate 60 (55%) 31 (28.4%) 18 (16.5%) 109 (51.4%) 
Poor 14 (21.9%) 18 (16.5%) 21 (32.8%) 64 (30.2%) 
Total 109 (51.4%) 63 (29.7%) 40 (18.9%) 212 (100%) 
HEPATOLOGY Vol. 34, No.3, 2001 
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FIG. 5. Correlation between apoptosislmitosis ratio and the cumulative 
tumor-free survival after transplantation. 
Appreciation of tumor heterogeneity is also a consistent conclu-
sion in molecular and genetic analyses of HCC,23,30,37,38 which 
show that both genetic and epigenetic alterations contribute 
to tumor phenotype.30,31.37-40 Genes with reported somatic 
mutations include the tumor suppressor genes such as p53, 
mannose-6-phosphatelinsulin-like factor 2 receptor, {3-cate-
nin, p16, and retinoblastoma, which are either directly or 
indirectly involved with cell cycle progression or invasive 
growth. Germ line mutations of p16, adenomatosis polyposis 
coli, and breast cancer gene 2 have also been reported,38 as 
have oncogenic activation of several cellular genes such as 
cYclin D and cyclin A.38 
Regulation of mitosis and apoptosis through the cell cycle-
related proteins p16, p21, p27, and cyclin D is an intriguing 
aspect of liver carcinogenesis.4,32,38,41-43 For example, inacti-
vation of p 16 by posttranscriptional regulation appears to par-
ticipate in both the early developmental stage and in tumor 
progression,38 whereas reduced p21 expression caused by p53 
mutations seems to occur at a later stage. Consistent with our 
observation of an altered apoptosis/mitosis ratio and aggres-
sive biologic behavior, poorly differentiated tumors and the 
inner nodules of heterogeneous tumors more often show p53 
mutations,32,38 and Rb dysfunction is associated with malig-
nant progression and metastasis of HCC.30 Given the results 
of this study, it will be important in future studies to carefully 
correlate genetic alterations with tumor morphology and 
growth characteristics using microdissection. 
Although most HCCs begin as well-differentiated neo-
plasms that slowly enlarge and evolve, as discussed above, a 
small subset (roughly <20%) quickly acquire aggressive char-
acteristics similar to flat carcinomas of the bladder2l,22 and 
colon. 18 Because of this biology, prognostication of tumor 
behavior based on size alone will be inaccurate for a minority 
of cases. It will be interesting to determine whether these early 
aggressive lesions follow molecular pathways distinct from 
more conventional tumors (or share some pathways but not 
others), similar to the spectrum of genetic alterations uncov-
ered in flat and polypoid bladder20 and colonl8 cancers. 
Angiogenesis is an obviously important aspect of hepatic 
carcinogenesis, which already is used for tumor treatment. 
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Unfortunately, this stuqy failed to show a correlation between 
microvascular density and tumor aggressiveness, size, differ-
entiation, mitosis, or any level of vascular invasion, which is 
consistent with some previous studies28,44,45 but in contrast 
with others,27,28 However, if the number of complete vessels 
within a tumor was more than 5, the apoptotic cell number 
decreased, suggesting that angiogenesis might contribute to 
tumor progression by altering the apoptosis/mitosis ratio, In 
our opinion, the lack of consensus between HCC angiogenesis 
and tumor biology is at least partially attributable to lack of 
standardized quantification methods. 27,28,44,45 In addition, the 
development of large complete vessels in HCC angiogenesis is 
significantly different than other neoplasms46,47 and current 
methods do not consider the caliber of any complete vessels. 
More work is needed in this area. 
Lastly, it is likely that the TNM system will require modifi-
cation to better predict prognosis, as we previously suggested. 14 
Although some aspects of tumor progression are captured 
with the current system, the variable Significance of multifo-
cality and other aspects of tumor progression, such as micro-
scopic vascular invasion and the apoptosislmitosis ratio, are 
ignored, For example, this study showed that if 2 separate 
HCCs maintain a relatively high apoptosislmitosis ratio, they 
probably arose as 2 separate Tl primaries and do not represent 
a multifocal aggressive neoplasm arising from intrahepatic 
metastasis. 
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